$RGNX: REGENXBIO to Participate in Upcoming Investor Conferences

Date: Wednesday, March 6th, 2019

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: ROCKVILLE, Md., March 6, 2019 /PRNewswire/ — REGENXBIO Inc. (NASDAQ:RGNX), a leading clinical-stage biotechnology company seeking to improve lives …

Full article address: https://www.benzinga.com/pressreleases/19/03/r13307916/regenxbio-to-participate-in-upcoming-investor-conferences

Related News:

$AMGN $SRPT $WING $RGNX $V: Cramer’s lightning round: People doubted this stock, but they’re wrong

$TAC $RGNX: Hedge Funds Have Never Been This Bullish On TransAlta …

$RGNX: Here’s What Hedge Funds Think About Regenxbio Inc (RGNX)

$RGNX: REGENXBIO to Present at the Raymond James 2019 Life Sciences …

$RGNX: REGENXBIO completes dosing in mid-stage wet AMD study

$RGNX: REGENXBIO Announces Completion of Dosing for Phase I/IIa …

$RGNX: FDA approves most expensive gene therapy ever — and here is its …

$ACOR $RGNX: REGENXBIO (RGNX) Catches Eye: Stock Jumps 7.4%

$RGNX $NVS: REGENXBIO up 5% premarket on FDA nod for gene therapy …

$NVS $RGNX: Approval of a Game-Changing Gene Therapy for SMA Delivers a …

$RGNX: REGENXBIO Announces First FDA Approval of a Gene Therapy …

Latest News:

$BIIB: Biogen Rises on Strong Second-Quarter Earnings, Guidance Boost

$HOG: Harley Davidson second-quarter sales continued to slide as profit falls 19%

$VYM: What If the Fed Does Cut Rates and It’s Already Totally Priced In?

$PEBO: Peoples Bancorp Inc. Declares Quarterly Dividend

$IRDM: Iridium Announces Second-Quarter 2019 Results; Reaffirms 2019 …

$F: Ford to invest another $50 million in its Chicago operations, create …

$PYPL: Why PayPal Stock Could Have a Strong Earnings Season

$UBS: UBS Q2 global wealth profit rises, i-banking fals

$AVY: Avery Dennison tightened FY2019 guidance

$MSFT: Microsoft Caps Off an Amazing 2019. Here’s Why It Can Repeat in …

$HXL: More on Hexcel’s Q2 results; raises FY19 EPS guidance